Form Type: 4/A

SEC EDGAR Link
Accession Number:0001179110-21-005054
Date:2020-06-02
Issuer: TELADOC HEALTH, INC. (TDOC)
Original Submission Date:2020-06-05

Reporting Person:

GOREVIC JASON N
C/O TELADOC HEALTH, INC.,
2 MANHATTANVILLE ROAD, SUITE 203 PURCHASE, NY 10577

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2020-06-02 M 23,067 a $1.67 694,350 direct
COMMON STOCK 2020-06-02 M 1,933 a $6.01 696,283 direct
COMMON STOCK 2020-06-02 S 1,600 d $165.60 694,683 direct
COMMON STOCK 2020-06-02 S 3,899 d $166.73 690,784 direct
COMMON STOCK 2020-06-02 S 4,916 d $167.70 685,868 direct
COMMON STOCK 2020-06-02 S 5,791 d $168.80 680,077 direct
COMMON STOCK 2020-06-02 S 7,794 d $169.66 672,283 direct
COMMON STOCK 2020-06-02 S 600 d $170.41 671,683 direct
COMMON STOCK 2020-06-02 S 100 d $171.32 671,583 direct
COMMON STOCK 2020-06-02 S 300 d $172.58 671,283 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
EMPLOYEE STOCK OPTION (RIGHT TO BUY) 1.67 2020-06-02 deemed execution date M 23,067 (d) 2023-12-11 common stock 23,067 $1.67 0 direct
EMPLOYEE STOCK OPTION (RIGHT TO BUY) 6.01 2020-06-02 deemed execution date M 1,933 (d) 2024-12-22 common stock 1,933 $6.01 120,310 direct
Footnotes
IDfootnote
f1 the reporting person was informed by the broker of the reported transactions on june 3, 2020. accordingly, pursuant to rule 16a-3(g)(2), the deemed execution date was june 3, 2020.
f2 the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan that was adopted by the reporting person on march 4, 2020.
f3 represents the weighted average price of transactions ranging from $165.23 to $166.13, inclusive. the reporting person undertakes to provide, upon request by the sec staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 3 through 8 to this form 4.
f4 represents the weighted average price of transactions ranging from $166.24 to $167.11, inclusive.
f5 represents the weighted average price of transactions ranging from $167.25 to $168.24, inclusive.
f6 represents the weighted average price of transactions ranging from $168.27 to $169.26, inclusive.
f7 represents the weighted average price of transactions ranging from $169.28 to $170.27, inclusive.
f8 represents the weighted average price of transactions ranging from $170.31 to $170.51, inclusive.
f9 the option vested as to 25% of the shares on january 1, 2014. the remainder of the shares vested in 36 substantially equal monthly installments thereafter.
f10 the option vested as to 25% of the shares on december 22, 2015. the remainder of the shares vested in 36 substantially equal monthly installments thereafter.

Elevate your investments